HRAS and spitzoid melanoma: Spitzoid melanomas often necessitate a panel of melanocytic and proliferation markers, with molecular testing (e.g., for Harvey rat sarcoma viral oncogene homolog (HRAS) mutations or anaplastic lymphoma kinase (ALK) fusions) playing a confirmatory role [95].